While the US Supreme Court will soon be weighing in on whether or not genes are patentable in the Myriad Genetics case, we‘ve also been following a similar case in Australia. There, a bunch of cancer patients took Myriad to court, arguing that the patent on BRCA1 is invalid (this same gene is part of the US case). Unfortunately, the court has decided that genes are, in fact, patentable if they‘ve been isolated